Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT03843528 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03843528
Sponsor: Johns Hopkins All Children's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Mixed Phenotype Acute Leukemia Juvenile Myelomonocytic Leukemia

Start date: 2019-05-01
Primary completion: 2027-07-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.